Atrial fibrillation ablation: study on sex differences
Part of Heart & circulation clinical trials.
This research compares how atrial fibrillation (AF) affects men and women differently. If you are having your first catheter ablation for AF and are between 18 and 80, this study may help doctors understand outcomes better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with atrial fibrillation that comes and goes (paroxysmal) or lasts less than a year (persistent).
- This is your first catheter ablation procedure for AF.
- You have not had a prior ablation or surgical Maze procedure.
- You are able to provide consent and are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how sex differences might affect the success of a first-time procedure to fix an irregular heartbeat (atrial fibrillation). It uses special CT scans to measure heart structures, and only includes patients who had the procedure done a certain way.
This study compares two ways to perform a heart procedure called ablation to treat atrial fibrillation, a condition that causes an irregular heartbeat. The goal is to find out which approach is safer and more effective at restoring a normal heart rhythm.
This study compares two techniques for treating persistent atrial fibrillation: one uses standard anatomy-based ablation, and the other uses a special mapping system to guide the procedure. It aims to find which method works better for people who have not had prior ablation.
This study compares two types of ablation (a procedure that uses energy to fix irregular heartbeats) for people with persistent atrial fibrillation. It tests whether adding extra treatment to the back of the heart's left upper chamber helps improve outcomes compared to standard treatment alone.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This trial is testing a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which treats atrial fibrillation (a type of irregular heartbeat). It is for people who are having this procedure for the first time and whose heart is in a normal rhythm at the time of treatment.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.